Read the story behind the quarter.
Income statement, balance sheet, and cash flow—connected to the customer situation, marketing choices, operating indicators, and real competitive alternatives.
Five reports to start with
Medtronic FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Medtronic reported $36.4B in revenue and $6.5B in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2026 · STESTERIS FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
STERIS reported $5.9B in revenue and $1.1B in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2026 · CRVLCorVel FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
CorVel reported $959M in revenue and $110M in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2026 · HAEHaemonetics FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Haemonetics reported $1.3B in revenue and $157M in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2026 · DOCSDoximity FY2026 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Doximity reported $645M in revenue and $215M in operating profit for FY2026. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →121 earnings analyses
Primary sources · US GAAP · USD millions
Henry Schein FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Henry Schein reported $13.2B in revenue and $653M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · RVTYRevvity FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Revvity reported $2.9B in revenue and $357M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · GMEDGlobus Medical FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Globus Medical reported $2.9B in revenue and $480M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · MMSIMerit Medical Systems FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Merit Medical Systems reported $1.5B in revenue and $185M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · TMDXTransMedics Group FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
TransMedics Group reported $605M in revenue and $109M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · AVNSAvanos Medical FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Avanos Medical reported $701M in revenue and -$62M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · ADUSAddus HomeCare FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Addus HomeCare reported $1.4B in revenue and $139M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · OPCHOption Care Health FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Option Care Health reported $5.7B in revenue and $338M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · CORTCorcept Therapeutics FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Corcept Therapeutics reported $761M in revenue and $100M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · OGNOrganon FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Organon reported $6.2B in revenue and $425M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · ELANElanco Animal Health FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Elanco Animal Health reported $4.7B in revenue and -$224M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · WATWaters FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Waters reported $3.2B in revenue and $803M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · GKOSGlaukos FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Glaukos reported $507M in revenue and -$200M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · HIMSHims & Hers Health FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Hims & Hers Health reported $2.3B in revenue and $106M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · ABBVAbbVie FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
AbbVie reported $61.2B in revenue and $15.1B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · MRNAModerna FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Moderna reported $1.9B in revenue and -$3.1B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · ABTAbbott Laboratories FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Abbott Laboratories reported $44.3B in revenue and $8.1B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · ZBHZimmer Biomet FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Zimmer Biomet reported $8.2B in revenue and $1.1B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · IDXXIDEXX Laboratories FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
IDEXX Laboratories reported $4.3B in revenue and $1.4B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · AMNAMN Healthcare Services FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
AMN Healthcare Services reported $2.7B in revenue and -$55M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · HUMHumana FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Humana reported $129.7B in revenue and $2.7B in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · GHGuardant Health FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Guardant Health reported $982M in revenue and -$437M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · TNDMTandem Diabetes Care FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
Tandem Diabetes Care reported $1B in revenue and -$187M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →FY2025 · IRTCiRhythm Technologies FY2025 Earnings: How turning clinical evidence, access, adherence, and professional trust shaped growth and margin
iRhythm Technologies reported $747M in revenue and -$57M in operating profit for FY2025. We connect the customer situation and business mechanism to the income statement, balance sheet, and cash flow.
Read earnings analysis →
